Latest filing published 01 May 2023 for CHEMBIO DIAGNOSTICS, INC., €1,044.
Insider track record
Charles Caso: trading record in brief
Charles Caso discloses dealings in Chembio Diagnostics, Inc. to SEC (Form 4). In total, 7 filings cover trades dated from 1 June 2022 to 26 April 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 1 May 2023, reports a share grant of €1,009 in Chembio Diagnostics, Inc. Filings reach the SEC (Form 4) feed a median of 51 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Charles Caso
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,444 shares@ US$0.775.1% of flowCommon StockSEC:0001140361-23-022231:1
- 10,311 shares@ US$0.4420.9% of flowCommon StockSEC:0001140361-23-022231:3
- 2,775 shares@ US$0.394.9% of flowCommon StockSEC:0001140361-23-022231:5
- 29,333 sharesCommon StockSEC:0001140361-23-022231:2
- 7,885 sharesCommon StockSEC:0001140361-23-022231:4
- 34,674 shares@ US$0.4569.0% of flowCommon StockSEC:0001140361-23-022231:6
- 4,101 sharesCommon StockSEC:0001140361-23-022231:0
7 of 7 declarations